Antigen Presentation by Murine Dendritic Cells is Nuclear Factor‐kappa B Dependent Both In Vitro and In Vivo
Authors:
Open Access
- 21 July 2003
- journal article
- website
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 58 (2) , 165-172
Abstract
Antigen presentation is a key rate‐limiting step in the immune response. Dendritic cells (DCs) have been reported to be the most potent antigen‐presenting cells for naïve T cells, but little is known about the biochemical pathways that regulate this function. We here demonstrate that mature murine DC can be infected with adenovirus at high efficiency (>95%) and that an adenovirus transferring the endogenous inhibitor IκBα blocks nuclear factor‐kappa B (NF‐κB) function in murine DC. This result indicates that antigen presentation in the mixed leucocyte reaction is NF‐κB dependent, confirming data with human DC in vitro. However, the importance of this finding depends on verifying that this is true also in vivo. Using delayed type hypersensitivity with allogeneic cells, we show that NF‐κB inhibition had a marked immunosuppressive effect in vivo. These results thus establish NF‐κB as an effective target for blocking DC antigen presentation and hence inhibiting T‐cell‐dependent immune responses. This finding has potential implications for the development of therapeutic agents for use in various pathological conditions of the immune system, including allergy and autoimmunity, and also in transplantation.Keywords
This publication has 30 references indexed in Scilit:
- Effective antigen presentation by dendritic cells is NF-κB dependent: coordinate regulation of MHC, co-stimulatory molecules and cytokinesInternational Immunology, 2001
- Efficient adenoviral infection with IκBα reveals that macrophage tumor necrosis factor α production in rheumatoid arthritis is NF-κB dependentProceedings of the National Academy of Sciences, 1998
- Dendritic cells and the control of immunityNature, 1998
- Dendritic Cell Development: Multiple Pathways to Nature's AdjuvantsStem Cells, 1997
- Prevention and amelioration of collagen‐induced arthritis by blockade of the CD28 co‐stimulatory pathway: requirement for both B7‐1 and B7‐2European Journal of Immunology, 1996
- CTLA4-Ig PLUS BONE MARROW INDUCES LONG-TERM ALLOGRAFT SURVIVAL AND DONOR-SPECIFIC UNRESPONSIVENESS IN THE MURINE MODELTransplantation, 1996
- Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAEImmunity, 1995
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.Journal of Experimental Medicine, 1994
- Dendritic cells induce T cell proliferation to synthetic antigens under Ir gene control.Journal of Experimental Medicine, 1980
- IDENTIFICATION OF A NOVEL CELL TYPE IN PERIPHERAL LYMPHOID ORGANS OF MICEJournal of Experimental Medicine, 1973